Our research is funded by:

Søraas A, Engvig A, Alnæs D, Karim LN, Danilova E, Istre MS, Nygaard S, Utgård TR, Ceprnjic S, Reiakvam O, Edvardsen E, Westlye LT, Nygaard AB, Dahl JA, Nissen-Meyer LSH, Ihle-Hansen H, Holland P (2026)
Interstitial fluid rejuvenation through young-donor plasma exchange in cognitively impaired patients: a pilot safety and feasibility study
Geroscience (in press)
DOI 10.1007/s11357-026-02435-0, PubMed 42489967

Brunvoll SH, Fagerland MW, Nygaard AB, Ellingjord-Dale M, Istre MS, Landrø NI, Bø R, Holland P, Kalleberg KT, Dahl JA, Søraas A (2026)
Long COVID symptoms before and 3-35 months after SARS-CoV-2 infection in a Norwegian prospective cohort study, symptoms over the pandemic, and different virus variants
Int J Infect Dis, 170, 108822
DOI 10.1016/j.ijid.2026.108822, PubMed 42208931

Magnúsdóttir I, Nygaard AB, Hoffart A, Murphy G, Kõiv K, Barker MM, Lovik A, Unnarsdóttir AB, Kähler AK, Hauksdóttir A, Thordardottir EB, Eyþórsson E, Gísladóttir EU, Joyce EE, Frans EM, Tómasson G, Hjördísar Jónsdóttir HL, Rúnarsdóttir H, Harðardóttir H, Dahl JA, Jakobsdóttir J, Kalleberg KT, Ásbjörnsdóttir KH, Ellingjord-Dale M, Istre MS et al. (2026)
Acute COVID-19 severity and impaired cognitive function up to 32 months after diagnosis: an observational study
BMC Med, 24 (1)
DOI 10.1186/s12916-026-04856-2, PubMed 41965722